Decreased plasma cholesterol esterification and cholesteryl ester transfer in hypopituitary patients on glucocorticoid replacement therapy

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 60, Issue 3, 2000, Pages 189-198

  Beentjes, J A M ^b   Van Tol, A ^b   Sluiter, W J ^b   Dullaart, R P F ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

Cholesterol esterification; Cholesteryl ester transfer; Cholesteryl ester transfer protein; Glucocorticoids; Growth hormone deficiency; High density lipoproteins; Hypopituitarism; Lecithin: cholesterol acyl transferase; Phospholipid transfer protein

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ESTERIFICATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0034044653     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655100750044839     Document Type: Article

References (53)

1. 1 Rosén T, Bengtsson BȦ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8.
2. 2 Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab 1996; 81: 1169-72.
3. 3 Bülow B, Hagmar L, Mikoczy Z, Nordström CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997; 46: 75-81.
4. 4 Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 1992; 340: 1188-92.
5. 5 Rosén T, Eden S, Larson G, Wilhelmsen L, Bengtsson BȦ. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993; 129: 195-200.
6. 6 Carroll PV, Christ ER, Bengtsson BȦ, Carlsson L, Christiansen JS, Clemmons D, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998; 83: 382-95.
7. 7 Al-Shoumer KAS, Cox KH, Hughes CL, Richmond W, Johnston DG. Fasting and post-prandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. J Clin Endocrinol Metab 1997; 82: 2653-9.
8. 8 Rosén T, Wilhelmsen L, Bengtsson BȦ. Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency. Clin Endocrinol 1998; 48: 525-6.
9. 9 Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, et al. Daily Cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72: 39-45.
10. 10 Kraan GP, Dullaart RPF, Pratt JJ, Wolthers BG, Drayer NM, De Bruin R. The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab 1998; 83: 1247-52.
11. 11 DeVile CJ, Stanhope R. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism. Clin Endocrinol 1997; 47: 37-41.
12. 12 Kissebah AH. 'Stress' hormones and lipid metabolism. Proc R Soc Med 1974; 67: 665-7.
13. 13 Luton JP, Richard C, Laudat MH, Pinon JC, Bricaire H. Cardiovascular diseases and lipid abnormalities in Cushing's syndrome. Nouv Presse Med 1982; 11: 2693-8.
14. 14 Stone NJ. Secondary causes of hyperlipedemia. Med Clin North Am 1994; 78: 117-41.
15. 15 Andrews RC, Walker BR. Glucocorticoids and insulin resistance. Old hormones, new targets. Clin Sci 1999; 96: 513-23.
16. 16 Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032-6.
17. 17 Tu AY, Nishida HI, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268: 23098-105.
18. 18 Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 1988; 27: 25-9.
19. 19 Von Eckardstein A, Jauhiainen M, Huang Y, Metso J, Langer C, Pussinen P, et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. Biochim Biophys Acta 1996; 1301: 255-62.
20. 20 Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017-58.
21. 21 Dullaart RPF, Groener JEM, Erkelens DW. Cholesterylester transfer between lipoproteins. Diab Nutr Metab 1991; 4: 329-43.
22. 22 Tall AR. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255-74.
23. 23 Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-28.
24. 24 Bruce C, Tall AR. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis. Curr Opin Lipidol 1995; 6: 306-11.
25. 25 Barter PJ, Rye KA. Molecular mechanisms of reverse cholesterol transport. Curr Opin Lipidol 1996; 7: 82-7.
26. 26 Beentjes JAM, Tjeerdsma G, Sluiter WJ, Dullaart RPF. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia. Clin Endocrinol 1996; 45: 391-8.
27. 27 Toogood AA, Beardwell CG, Shalet SM. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol 1994; 41: 511-6.
28. 28 Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-7.
29. 29 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
30. 30 Demacker PN, Hijmans AG, Vos-Janssen HE, Van't Laar A, Jansen AP. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin Chem 1980; 26: 1775-9.
31. 31 Dullaart RPF, Sluiter WJ, Dikkeschei LD, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188-94.
32. 32 Groener JEM, Pelton RW, Kostner GM. Improved estimation of cholesteryl ester transfer/ exchange activity in serum or plasma. Clin Chem 1986; 32: 283-6.
33. 33 Floren CH, Chen CH, Franzen J, Albers JJ. Lecithin: cholesterol acyltransferase in liver disease. Scand J Clin Lab Invest 1987; 47: 613-7.
34. 34 Hannuksela M, Marcel YL, Kesaniemi YA, Savolainen MJ. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737-44.
35. 35 Speijer H, Groener JEM, Van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159-68.
36. 36 Channon KM, Clegg RJ, Bhatnagar D, Ishola M, Arrol S, Durrington PN. Investigation of lipid transfer in human serum leading to the development of an isotopic method for the determination of endogenous cholesterol esterification and transfer. Atherosclerosis 1990; 80: 217-26.
37. 37 Dullaart RPF, Riemens SC, Scheek LM, Van Tol A. Insulin decreases plasma cholesterylester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Invest 1999; 29: 663-71.
38. 38 Sutherland WH, Walker RJ, Lewis-Barned NJ, Pratt H, Tillman HC. Plasma cholesteryl ester transfer in patients with non-insulin dependent diabetes mellitus. Clin Chira Acta 1994; 231: 29-38.
39. 39 Wolthers BG, De Vries IJ, Volmer M, Nagel GT. Detection of 3 beta-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis. Clin Chim Acta 1987; 169: 109-16.
40. 40 Zumoff B, Fukushima DK, Hellman L. Intercomparison of four methods for measuring Cortisol production. J Clin Endocrinol Metab 1974; 38: 169-75.
41. 41 Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol 1996; 45: 605-11.
42. 42 Jover E, Paradinas C, Prieto J, Arranz MT, Para J, Velasco R. Study of the effect of ACTH and cortisol on the plasms lipids in man using thin-layer chromatography. J Med 1976; 7: 131-42.
43. 43 Jansen H, Van Tol A, Auwerx J, Skretting G, Staels B. Opposite regulation of hepatic lipase and lecithin: cholesterol acyltransferase by glucocorticoids in rats. Biochim Biophys Acta 1992; 1128: 181-5.
44. 44 Riemens SC, Van Tol A, Stulp BK, Dullaart RPF. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin:cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res 1999; 40: 1467-74.
45. 45 Radeau T, Robb M, Lau P, Borthwick J, McPherson R. Relationship of adipose tissue cholesteryl ester transfer protein (CETP) mRNA to plasma concentrations of CETP in man. Atherosclerosis 1998; 139: 369-76.
46. 46 Tall AR, Granot E, Brocia R, Tabas I, Hesler CB, Williams K, et al. Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein. J Clin Invest 1987; 79: 1217-25.
47. 47 Mann CJ, Yen FT, Grant AM, Bihain BE. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 1991; 88: 2059-66.
48. 48 Riemens SC, Van Tol A, Sluiter WJ, Dullaart RPF. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein. Atherosclerosis 1998; 140: 71-9.
49. 49 Taskinen MR, Nikkilä EA, Pelkonen R, Sane T. Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 1983; 57: 619-26.
50. 50 Hoeg JM, Santamarina-Fojo S, Bérard AM, Cornhill JF, Herderick EE, Feldman SH, et al. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci USA 1996; 93: 11448-53.
51. 51 Zhong S, Sharp DS, Grove JS, Bruce C, Yano K, Curb JD, et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest 1996; 97: 2917-23.
52. 52 Tall AR. Plasma lipid transfer proteins. J Lipid Res 1986; 27: 361-7.
53. 53 Fielding CJ, Havel RJ. Cholesteryl ester transfer protein: friend or foe? J Clin Invest 1996; 97: 2687-8.